Class of 2025
For revolutionary discoveries pertaining to the molecular pathogenesis of leukemia, lymphoma, and neuroblastoma, including identifying novel oncogenes such E2A-HLF and NPM-ALK; for elucidating oncogene-driven signaling pathways; and for developing transgenic zebrafish models to identify new molecular targets for childhood cancers.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]